JP2015518494A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518494A5 JP2015518494A5 JP2015511473A JP2015511473A JP2015518494A5 JP 2015518494 A5 JP2015518494 A5 JP 2015518494A5 JP 2015511473 A JP2015511473 A JP 2015511473A JP 2015511473 A JP2015511473 A JP 2015511473A JP 2015518494 A5 JP2015518494 A5 JP 2015518494A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- products
- international
- publication
- application publication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CYQFCXCEBYINGO-DLBZAZTESA-N Dronabinol Natural products C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@H]21 CYQFCXCEBYINGO-DLBZAZTESA-N 0.000 description 2
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 229960004242 dronabinol Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261643713P | 2012-05-07 | 2012-05-07 | |
| US61/643,713 | 2012-05-07 | ||
| PCT/US2013/033991 WO2013169406A1 (en) | 2012-05-07 | 2013-03-27 | Manufacturing and packaging room temperature stable dronabinol capsules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015518494A JP2015518494A (ja) | 2015-07-02 |
| JP2015518494A5 true JP2015518494A5 (enExample) | 2016-04-21 |
Family
ID=49513014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511473A Pending JP2015518494A (ja) | 2012-05-07 | 2013-03-27 | 室温安定性ドロナビノールカプセルの製造および包装 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8741341B2 (enExample) |
| EP (1) | EP2846782A4 (enExample) |
| JP (1) | JP2015518494A (enExample) |
| CA (1) | CA2872248A1 (enExample) |
| WO (1) | WO2013169406A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11911361B2 (en) | 2014-05-29 | 2024-02-27 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
| US11331279B2 (en) | 2014-05-29 | 2022-05-17 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
| US12544389B2 (en) | 2014-05-29 | 2026-02-10 | Fresh Cut Development, Llc | Stable cannabinoid formulations |
| JP6920197B2 (ja) | 2014-06-11 | 2021-08-18 | ポビバ コーポレーションＰｏｖｉｖａ Ｃｏｒｐ． | 親油性活性剤を注入された飲食料品組成物とその使用方法 |
| ES2835720T3 (es) * | 2014-06-11 | 2021-06-23 | Poviva Corp | Composiciones de alimentos y bebidas infusionadas con agentes activos lipófilos y métodos de uso de las mismas |
| GB2530001B (en) * | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| CA2985332C (en) | 2015-05-18 | 2023-01-03 | 5071, Inc. | Homogenous cannabis compositions and methods of making the same |
| ES2938560T5 (en) * | 2015-05-28 | 2026-04-24 | Fresh Cut Dev Llc | Stable cannabinoid formulations |
| US10702495B2 (en) | 2017-02-20 | 2020-07-07 | Nexien Biopharma, Inc. | Method and compositions for treating dystrophies and myotonia |
| EP3737371A4 (en) * | 2018-01-10 | 2021-10-06 | Benuvia Therapeutics, LLC | PROCEDURE FOR STABILIZATION OF DRONABINOL |
| EP3750528A1 (en) | 2019-06-11 | 2020-12-16 | Nexien Biopharma, Inc. | Compositions for treating dystrophies and myotonia |
| CA3162623A1 (en) * | 2019-11-25 | 2021-06-03 | Gary Stephen Shuster | Aerosolization systems, methods, and apparatuses |
| CA3172889C (en) | 2020-04-20 | 2024-05-28 | John Docherty | Compositions and methods for enhanced delivery of antiviral agents |
| US20230390209A1 (en) * | 2020-10-23 | 2023-12-07 | Fuji Capsule Co., Ltd. | Cannabidiol-containing seamless soft capsule |
| EP4591855A1 (en) | 2024-01-23 | 2025-07-30 | Echo Pharmaceuticals B.V. | Stable dronabinol compositions |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4917671U (enExample) * | 1972-05-17 | 1974-02-14 | ||
| JPS60183374A (ja) * | 1984-02-24 | 1985-09-18 | 大日本印刷株式会社 | 脱酸素密封包装物の製造法 |
| PL209134B1 (pl) * | 2002-04-03 | 2011-07-29 | Solvay Pharm Bv | Sposób wytwarzania kompozycji farmaceutycznej zawierającej naturalny związek kanabinoidowy i kompozycja farmaceutyczna otrzymywana tym sposobem |
| PT1542657E (pt) | 2002-08-14 | 2012-02-29 | Gw Pharma Ltd | Formulações líquidas canabinóides para administração pela mucosa |
| JP4341835B2 (ja) * | 2004-04-13 | 2009-10-14 | 日本化薬株式会社 | カプセル剤の保存容器並びに保存方法 |
| US7633097B2 (en) | 2004-09-23 | 2009-12-15 | Philips Lumileds Lighting Company, Llc | Growth of III-nitride light emitting devices on textured substrates |
| AU2005314021B2 (en) * | 2004-12-09 | 2010-02-11 | Insys Therapeutics, Inc. | Room-temperature stable dronabinol formulations |
| JP5053544B2 (ja) * | 2004-12-28 | 2012-10-17 | 株式会社カネカ | 還元型補酵素ｑ１０の保存方法 |
| US20090169586A1 (en) * | 2006-03-24 | 2009-07-02 | Ian Simon Tracton | Stable packaged dosage form and process therefor |
| US8039509B2 (en) * | 2006-11-10 | 2011-10-18 | Johnson Matthey Public Limited Company | Composition comprising (−)-Δ9-trans-tetrahydrocannabinol |
| US8222292B2 (en) | 2007-08-06 | 2012-07-17 | Insys Therapeutics, Inc. | Liquid cannabinoid formulations |
| WO2009020666A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
| US20120043242A1 (en) * | 2010-08-19 | 2012-02-23 | Andrew David Hospodor | Medicinal cannabis fatty foodstuff |
| EP2621509A4 (en) | 2010-09-15 | 2016-08-03 | Synergy Pharmaceuticals Inc | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHOD OF USE |
-
2013
- 2013-03-20 US US13/847,875 patent/US8741341B2/en not_active Expired - Fee Related
- 2013-03-27 EP EP13787688.4A patent/EP2846782A4/en not_active Withdrawn
- 2013-03-27 CA CA2872248A patent/CA2872248A1/en not_active Abandoned
- 2013-03-27 WO PCT/US2013/033991 patent/WO2013169406A1/en not_active Ceased
- 2013-03-27 JP JP2015511473A patent/JP2015518494A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268756B (en) | Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments | |
| HUE069593T2 (hu) | PD1 elleni monoklonális ellenanyag, azt tartalmazó gyógyászati készítmény és alkalmazása | |
| HUE061596T2 (hu) | Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben | |
| JP2014532727A5 (enExample) | ||
| JP2017515162A5 (enExample) | ||
| JP2014519662A5 (enExample) | ||
| JP2014513484A5 (enExample) | ||
| UY32649A (es) | "sales de 4-(dimetilamino)butil 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil)acetato" | |
| MX2019012757A (es) | Composicion farmaceutica para administracion oral que comprende enzalutamida. | |
| JP2016527801A5 (enExample) | ||
| EA201491517A1 (ru) | N-этил-n-фенил-1,2-дигидро-4,5-дигидрокси-1-метил-2-оксо-3-хинолинкарбоксамид, его получение и применения | |
| BR112013023575A2 (pt) | derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes | |
| HUE054609T2 (hu) | Elkészítési eljárás hagyományos kínai gyógyszer mikrocsepp pilulához, és a hagyományos kínai gyógyszer mikrocsepp pilula, amely ennek az eljárásnak az alkalmazásával van elkészítve | |
| EP3837238C0 (en) | CRYSTALLINE SALTS OF TRANILAST AND THEIR PHARMACEUTICAL USE | |
| RU2015136958A (ru) | 2-арил-2, 4-дигидрокси-2, 5-дигидро-3-гетерил-5-оксо-1н-пиррол-1-ил-4-метилбелзолсульфаниламиды, обладающие анальгетической активностью | |
| BR112013024196A2 (pt) | complexos de gálio, composições farmacêuticas e métodos de uso | |
| JP2019518052A5 (enExample) | ||
| JP2016513537A5 (enExample) | ||
| EP3065737A4 (en) | Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form | |
| CN110869382A (zh) | 甾体类衍生物fxr激动剂的结晶或无定型物、其制备方法和用途 | |
| BR112015028551A2 (pt) | derivados de pirimidin-4-il)óxi)-1h-indol-1-carboxamida e usos dos mesmos | |
| TH126235A (th) | สารดัดแปรผลึกที่คงตัวของ dopc | |
| 冯育军 | Self-destruction in the Mirror: A Lacanian Psychoanalysis of Death of A Salesman | |
| Wang et al. | Statins do not improve lung function decline in COPD? | |
| NOGAMI | Azimuth and distance unit in the biography of Dongyi, Book of Wei |